Clinical Trial: Evaluation of a Hemostatic and Sealing Agent to Prevent Surgical Complications After Axillary Lymphadenectomy
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Value of a Hemostatic and Sealing Agent for Preventing Seroma After Axillary Lymphadenectomy
Brief Summary: This study was intended to assess the value of a hemostatic and sealing agent, a collagen sponge coated with human coagulation factors (fibrinogen and thrombin) (TachoSil®), for decreasing occurrence of seroma after axillary lymphadenectomy.
Detailed Summary:
Sponsor: Hospital Universitario Virgen de la Arrixaca
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Hospital Universitario Virgen de la Arrixaca
Dates:
Date Received: February 26, 2009
Date Started: January 2008
Date Completion: November 2008
Last Updated: February 26, 2009
Last Verified: February 2009